Advertisement

International Journal of Clinical Pharmacy

, Volume 36, Issue 6, pp 1241–1250 | Cite as

Medication use review in Qatar: Are community pharmacists prepared for the extended professional role?

  • Ahmed Hussein Babiker
  • Louise Carson
  • Ahmed AwaisuEmail author
Research Article

Abstract

Background The incidence of chronic illnesses is increasing globally. Non-adherence to medications and other medication-related problems are common among patients receiving long-term medications. Medication use review (MUR) is a service provision with an accredited pharmacist undertaking structured, adherence-centered reviews with patients receiving multiple medications. MUR services are not yet available in community pharmacies in Qatar. Objective The current study aims to evaluate community pharmacists’ knowledge, attitudes, and perception towards establishing MUR as an extended role in patient care. Setting Private community pharmacies in Qatar including chains and independent pharmacies. Methodology A cross-sectional survey using a self-administered questionnaire was conducted among licensed community pharmacists from December 2012 to January 2013. Data analysis was conducted using descriptive and inferential statistics. Main outcome measures Knowledge, attitudes, and practices related to MUR concept and services. Results A total of 123 participants responded to the survey (response rate 56 %). The mean total knowledge score was 71.4 ± 14.7 %. An overwhelming proportion of the participants (97 %) were able to identify the scope of MUR in relation to chronic illnesses and at enhancing the quality of pharmaceutical care. Furthermore, 80 % of the respondents were able to identify patients of priority for inclusion in an MUR program. However, only 43 % of the participants knew that acute medical conditions were not the principal focus of an MUR service, while at least 97 % acknowledged that the provision of MUR services is a great opportunity for an extended role of community pharmacists and that MUR makes excellent use of the pharmacist’s professional skills in the community. The participants generally reported concerns about time, dedicated consultation area, and support staff as significant barriers towards MUR implementation. Conclusion This study suggests that community pharmacists in Qatar had sufficient knowledge about the concept of MUR and its scope, but there were still important deficiencies that warrant further education. The findings have important implications on policy and practice pertaining to the implementation of MUR as an extended role of pharmacists and as part of Qatar’s National Health Strategy to move primary health care forward.

Keywords

Community pharmacist Medication use review MUR Pharmaceutical services Professional role Qatar 

Notes

Acknowledgments

The authors would like to thank all community pharmacists who voluntarily participated in the study.

Funding

This study received no funding from any public or private entity. The statements made herein are solely the responsibility of the authors.

Conflicts of interest

The authors have no competing interests to declare.

References

  1. 1.
    Heneghan C, Blacklock C, Perera R, Davis R, Banerjee A, Gill P, et al. Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ Open. 2013;3:e003298.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Marcum ZA, Zheng Y, Perera S, Strotmeyer E, Newman AB, Simonsick EM, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Soc Adm Pharm. 2013;9:817–27.CrossRefGoogle Scholar
  3. 3.
    Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36:58–66.Google Scholar
  4. 4.
    Clinical Medication Review; A Practice Guide (2013) NHS Cumbria (Retrieved on 14 Feb 2014) from: http://www.cumbria.nhs.uk/ProfessionalZone/MedicinesManagement/Guidelines/MedicationReview-PracticeGuide2011.pdf.
  5. 5.
    Pharmaceutical Services Negotiating Committee (2012) MUR service specification (Retrieved on 12 June 2013) from: http://www.psnc.org.uk/data/files/PharmacyContractandServices/AdvancedServices/MUR_service_spec_-_Sept_2012.pdf.
  6. 6.
    Pharmaceutical Services Negotiating Committee (2012) and NHS Employers guidance on MURs for pharmacy contractors and their staff (Retrieved on 12 June 2013) from: http://www.psnc.org.uk/data/files/PharmacyContract/Contract_changes_2011/MUR_guidance_Sept_2012.pdf.
  7. 7.
    Latif A, Boardman H. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30:526–35.CrossRefGoogle Scholar
  8. 8.
    Livingstone C. Onwards and upwards with target MURs. Pharm J. 2010;284:57–60.Google Scholar
  9. 9.
    The National Health Service Act 2006 Directions (2013) The pharmaceutical services (advanced and enhanced services) England (Retrieved on 12 June 2013) from: http://www.psnc.org.uk/data/files/PharmacyContract/advanced_service/Pharm_Services_Adv_Enh_Services_Eng_Directions_2013.pdf.
  10. 10.
    Latif A, Pollock K, Boardman HF. The contribution of the medicines use review (MUR) consultation to counselling practice in community pharmacies. Patient Educ Couns. 2011;83:336–44.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Australian Government Department of Health and Aged Care (2006) Guiding principles for medication management in the community, Australian Pharmaceutical Advisory Council (Retrieved on 15 June 2013) from: http://www.health.gov.au/internet/main/publishing.nsf/content/23d9459ecd60326fca257391001c6cff/$file/booklet.pdf.
  12. 12.
    Pharmaceutical Society of Australia (2012) guideline for pharmacist providing Meds Check (Retrieved on 17 June 2013) from: http://www.psa.org.au/download/guidelines/3612-medscheck-guidelines-c.pdf.
  13. 13.
    DaVanzo J, Dobson A, Koeni L, Book R. Medication therapy management services: a Critical Review. J Am Pharm Assoc. 2005;45:580–7.CrossRefGoogle Scholar
  14. 14.
    Thompson CA. State-paid medication therapy management services succeed. Am J Health Syst Pharm. 2008;65:490–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Lee E, Braund R, Tordoff J. Examining the first year of medicines use review services provided by pharmacists in New Zealand: 2008. N Z Med J. 2009;122:26–35.Google Scholar
  16. 16.
    Kheir N, Fahey M. Pharmacy practice in Qatar: challenges and opportunities. South Med Rev. 2011;4:45–9.CrossRefGoogle Scholar
  17. 17.
    Zaidan M, Singh R, Wazaify M, Tahaineh L. Physicians’ perceptions, expectations, and experience with pharmacists at Hamad Medical Corporation in Qatar. J Multidiscip Healthc. 2011;4:85–90.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson P. Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ. 2008;72:133.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    El Hajj MS, Salem S, Mansoor H. Public’s attitudes towards community pharmacy in Qatar: a pilot study. Patient Prefer Adherence. 2011;5:405–22.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Qatar’s National Health Strategy 2011–2016. (Retrieved on 27 June 2013) from: http://www.nhsq.info/app/media/127.
  21. 21.
    Qatar’s National Health Strategy (2013) Executive summary update. Supreme Council of Health (Retrieved on 29 June 2013) from: http://nhs.fuegodigital.com/app/media/325.
  22. 22.
    Qatar National Vision 2030 National Health Strategy (Retrieved on 14 February 2014) from: http://www.nhsq.info/about-the-strategy/qatar-national-vision.
  23. 23.
    General Secretariat for Development Planning (2011) National Development Strategy 2011–16 (Retrieved on 26 June 2013) from: http://www.gsdp.gov.qa/gsdp_vision/docs/NDS_EN.pdf.
  24. 24.
    Raosoft sample size calculator. Raosoft, Inc. http://www.raosoft.com/samplesize.html.
  25. 25.
    Pharmaceutical Society of Australia (2011) Guideline for pharmacist providing home medication review (HMR) services (Retrieved on 20 June 2013) from: http://www.psa.org.au/download/practice-guidelines/home-medicines-review-services.pdf.
  26. 26.
    Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med. 2001;53(7):943–55.PubMedCrossRefGoogle Scholar
  27. 27.
    Hatah E, Braund R, Duffull S, Tordoff J. General practitioners’ perceptions of pharmacists’ new services in New Zealand. Int J Clin Pharm. 2012;34:364–73.PubMedCrossRefGoogle Scholar
  28. 28.
    Department of Health (DH); London (2003) A vision for pharmacy in the new NHS (Retrieved on 25 June 2013) from: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Consultations/Closedconsultations/DH_4068353.
  29. 29.
    Department of Health (DH); London (2005) Supporting people with long term conditions. An NHS and social care model to support local innovation and integration. (Retrieved on 25 June 2013) from: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4122574.pdf.
  30. 30.
    Hassell K, Seston EM, Schafheutle EI, Wagner A, Eden M. Workload in community pharmacies in the UK and its impact on patient safety and pharmacists’ well-being: a review of the evidence. Health Soc Care Community. 2011;19(6):561–75.PubMedCrossRefGoogle Scholar
  31. 31.
    Latif A, Pollock K, Boardman HF. Medicines use reviews: a potential resource or lost opportunity for general practice? BMC Fam Pract. 2013;14:57.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    General Secretariat for Development Planning (2008) Qatar National Vision (QNV) 2030 (Retrieved on 26 June 2013) from: http://www.gsdp.gov.qa/portal/page/portal/gsdp_en/qatar_national_vision/qnv_2030_document/QNV2030_English_v2.pdf.

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Ahmed Hussein Babiker
    • 1
  • Louise Carson
    • 2
  • Ahmed Awaisu
    • 3
    Email author
  1. 1.Pharmacy and Drug Control DepartmentSupreme Council of HealthDohaQatar
  2. 2.School of PharmacyQueen’s University BelfastBelfastUK
  3. 3.Clinical Pharmacy and Practice Section, College of PharmacyQatar UniversityDohaQatar

Personalised recommendations